Literature DB >> 17766999

Comment on: a case of Raynaud's phenomenon in mixed connective tissue disease responding to Rituximab therapy response.

L Dunkley, M Green, A Gough.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17766999     DOI： 10.1093/rheumatology/kem208

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  4 in total

1.  Good outcome after rituximab treatment for a mixed warm and cold autoimmune haemolytic anaemia.

Authors:  Brigitte Granel; Pascal Rossi; Fanny Bernard; Isabelle Dettori; Regis Costello; Anne Laurence Demoux; Denis Bagneres; Pierre Lafforgue; Yves Frances
Journal:  BMJ Case Rep       Date:  2009-03-06

Review 2.  Systematic review of the role of rituximab in treatment of antineutrophil cytoplasmic autoantibody-associated vasculitis, hepatitis C virus-related cryoglobulinemic vasculitis, Henoch-Schönlein purpura, ankylosing spondylitis, and Raynaud's phenomenon.

Authors:  Rbab Taha; Hadeel El-Haddad; Abdulqader Almuallim; Fatma Alshaiki; Elaf Obaid; Hani Almoallim
Journal:  Open Access Rheumatol       Date:  2017-12-15

3.  A case of subacute cutaneous lupus erythematosus in a patient with mixed connective tissue disease: successful treatment with plasmapheresis and rituximab.

Authors:  M Fantò; S Salemi; F Socciarelli; A Bartolazzi; G A Natale; I Casorelli; A Pavan; S Vaglio; R Di Rosa; R D'Amelio
Journal:  Case Rep Rheumatol       Date:  2013-07-28

4.  Severe Primary Raynaud's Disease Treated with Rituximab.

Authors:  Mohammed Shabrawishi; Abdurahman Albeity; Hani Almoallim
Journal:  Case Rep Rheumatol       Date:  2016-08-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.